+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

In vitro activity of ciprofloxacin and ofloxacin against mycobacterium tuberculosis mycobacterium avium mycobacterium africanum mycobacterium kansasii and strains of bcg



In vitro activity of ciprofloxacin and ofloxacin against mycobacterium tuberculosis mycobacterium avium mycobacterium africanum mycobacterium kansasii and strains of bcg



Immunitaet und Infektion 14(6): 203-207



The in vitro activity of ciprofloxacin and ofloxacin against 33 strains of mycobacteria was investigated in a comparative study. The resulting MIC values were compared with serum levels, measured in a cross-over study. Possible therapeutic application of these substances in mycobacterial infections are being discussed. We found the antimycobacterial activity of ciprofloxacin to be insufficient for its clinical application, whereas the corresponding MIC values for ofloxacin could be achieved in vivo. Further animal and clinical studies appear justified.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 005645452

Download citation: RISBibTeXText


Related references

In vitro activity of ciprofloxacin and ofloxacin against Mycobacterium tuberculosis, M. avium, M. africanum, M. kansasii and BCG strains. Immunitat und Infektion 14(6): 203-207, 1986

In vitro activities of norfloxacin and ciprofloxacin against mycobacterium tuberculosis mycobacterium avium complex mycobacterium chelonei mycobacterium fortuitum and mycobacterium kansasii. Antimicrobial Agents & Chemotherapy 26(1): 94-96, 1984

In vitro susceptibility of Mycobacterium tuberculosis, Mycobacterium africanum, Mycobacterium bovis, Mycobacterium avium, Mycobacterium fortuitum, and Mycobacterium chelonae to ticarcillin in combination with clavulanic acid. Antimicrobial Agents and ChemoTherapy 31(1): 132-133, 1987

Infections with mycobacterium avium human mycobacterium bovis mycobacterium tuberculosis mycobacterium kansasii mycobacterium intracellulare mycobacterium xenopei. Lancet (7558): 36, 1968

Monoclonal antibodies for the rapid differentiation of mycobacterium tuberculosis from mycobacterium bovis mycobacterium avium mycobacterium kansasii and mycobacterium xenopi. Abstracts of the Annual Meeting of the American Society for Microbiology 88: 139, 1988

Bacteriostatic and bactericidal activity of antituberculosis drugs against mycobacterium tuberculosis mycobacterium avium mycobacterium intracellulare complex and mycobacterium kansasii in different growth phases. Microbiology & Immunology 36(4): 361-368, 1992

Bacteriostatic and Bactericidal Activity of Antituberculosis Drugs against Mycobacterium tuberculosis, Mycobacterium avium-Mycobacterium intracellulare Complex and Mycobacterium kansasii in Different Growth Phases. Microbiology and Immunology 36(4): 361-368, 1992

Phylogenomic analysis of the species of the Mycobacterium tuberculosis complex demonstrates that Mycobacterium africanum, Mycobacterium bovis, Mycobacterium caprae, Mycobacterium microti and Mycobacterium pinnipedii are later heterotypic synonyms of Mycobacterium tuberculosis. International Journal of Systematic and Evolutionary Microbiology 68(1): 324-332, 2017

Determination of the optimum dose of some sensitins purified protein derivatives of mycobacterium tuberculosis strain 23 mycobacterium kansasii mycobacterium avium mycobacterium battey mycobacterium scrofulaceum with regard to their use in the lympho blast transformation test. Bulletin de l'Association des Diplomes de Microbiologie de la Faculte de Pharmacie de Nancy (125): 8-23, 1972

Heat stable enz acid phosphatase activity of mycobacteria mouse mycobacterium kansasii mycobacterium avium mycobacterium intracellulare mycobacterium fortuitum mycobacteria marinum mycobacterium runyonii. Japanese Journal of Bacteriology 22(9): 519-521, 1967

T-cellular immune reactions (in macrophage inhibition factor assay) against Mycobacterium paratuberculosis, Mycobacterium kansasii, Mycobacterium tuberculosis, Mycobacterium avium in patients with chronic inflammatory bowel disease. Gut 31(5): 529-535, 1990

T cellular immune reactions in macrophage inhibition factor assay against mycobacterium paratuberculosis mycobacterium kansasii mycobacterium tuberculosis mycobacterium avium in patients with chronic inflammatory bowel disease. Gut 31(5): 529-535, 1990

Bacteriostatic and bactericidal activity of ciprofloxacin and ofloxacin against Mycobacterium tuberculosis and Mycobacterium avium complex. Tubercle 68(4): 267-276, 1987

Direct detection of mycobacteria from bactec 12b bottles using commercially prepared chemiluminescent labeled nucleic acid probes for mycobacterium gordonae mycobacterium avium complex mycobacterium kansasii and mycobacterium tuberculosis. Abstracts of the Annual Meeting of the American Society for Microbiology 90: 142, 1990

In-vitro evaluation of the antibacterial activity of the essential oils of Micromeria barbata, Eucalyptus globulus and Juniperus excelsa against strains of Mycobacterium tuberculosis (including MDR), Mycobacterium kansasii and Mycobacterium gordonae. Journal of Infection and Public Health 2019, 2019